Long term follow-up of refractory/relapsed acute myeloid leukemia patients treated with the FLAG-Ida regimen as bridge therapy to allotransplantation: 10-year results from a single centre experience.

Autor: Delia M; Hematology and Stem Cell Transplantation Unit, Azienda Ospedaliero-Universitaria-Consorziale (AOUC) - Policlinico, Bari, Italy. Electronic address: mario.delia74@gmail.com., Gagliardi VP; Hematology and Stem Cell Transplantation Unit, Azienda Ospedaliero-Universitaria-Consorziale (AOUC) - Policlinico, Bari, Italy., Carluccio P; Hematology and Stem Cell Transplantation Unit, Azienda Ospedaliero-Universitaria-Consorziale (AOUC) - Policlinico, Bari, Italy., Attolico I; Hematology and Stem Cell Transplantation Unit, Azienda Ospedaliero-Universitaria-Consorziale (AOUC) - Policlinico, Bari, Italy., Contento C; Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), 'Aldo Moro' University - School of Medicine, Bari, Italy., Di Gennaro D; Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), 'Aldo Moro' University - School of Medicine, Bari, Italy., Albano F; Hematology and Stem Cell Transplantation Unit, Azienda Ospedaliero-Universitaria-Consorziale (AOUC) - Policlinico, Bari, Italy; Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), 'Aldo Moro' University - School of Medicine, Bari, Italy., Musto P; Hematology and Stem Cell Transplantation Unit, Azienda Ospedaliero-Universitaria-Consorziale (AOUC) - Policlinico, Bari, Italy; Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), 'Aldo Moro' University - School of Medicine, Bari, Italy.
Jazyk: angličtina
Zdroj: Leukemia research [Leuk Res] 2023 Jun; Vol. 129, pp. 107069. Date of Electronic Publication: 2023 Mar 24.
DOI: 10.1016/j.leukres.2023.107069
Abstrakt: Competing Interests: Conflict of interest There are no conflicts of interest to report.
Databáze: MEDLINE
Externí odkaz: